Parabilis Medicines, Inc. · NASDAQ:PBLS
Ra Capital Management, L.P. bought 244,593 Parabilis Medicines, Inc. shares (Form 4)
Traded Jul 20 to Jul 22, 2026 · Filed Jul 22, 2026
From Jul 20 to Jul 22, 2026, Ra Capital Management, L.P. (Director, 10% owner) bought 244,593 Parabilis Medicines, Inc. shares at an average US$28.29 for US$6.92M, leaving 26,529,686 shares. Filed Jul 22, 2026 (Form 4).
- Bought
- 244,593 shares
- Price
- US$28.29 average (US$27.13 to US$30.00)
- Value
- US$6.92M
- Holding after
- 26,529,686 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jul 20, 2026 | Voting Common Stock | Buy | 98,433 | US$27.13 | 26,383,526 | Indirect |
| Jul 20, 2026 | Voting Common Stock | Buy | 32,987 | US$27.72 | 26,416,513 | Indirect |
| Jul 21, 2026 | Voting Common Stock | Buy | 21,696 | US$27.96 | 26,438,209 | Indirect |
| Jul 21, 2026 | Voting Common Stock | Buy | 6,504 | US$29.17 | 26,444,713 | Indirect |
| Jul 21, 2026 | Voting Common Stock | Buy | 37,723 | US$30.00 | 26,482,436 | Indirect |
| Jul 22, 2026 | Voting Common Stock | Buy | 47,250 | US$29.77 | 26,529,686 | Indirect |
Source
Related
- Parabilis Medicines, Inc.
- Ra Capital Management, L.P.
- Parabilis Medicines, Inc. shareholders
- Schedule 13G · ARCH Venture Fund XII, L.P. · Aug 14, 2026
- Schedule 13G · FMR LLC · Aug 6, 2026
- Form 4 · Soleus Capital Group, LLC · Jun 29, 2026
- Schedule 13D · Ra Capital Management, L.P. · Jun 18, 2026
- Form 4 · Sebulsky Alan · Jun 16, 2026